Doxazosin Tablet
Product Images NDC 68071-4273

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 68071-4273). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

68071 4273 3

Label for Doxazosin 2 mg tablets by NuCare Pharmaceuticals, Inc., containing 30 tablets. The label indicates each tablet contains Doxazosin Mesylate USP equivalent to 2 mg Doxazosin. The tablets are described as round, cream to yellow, scored with 'C7' debossed on the unscored side. The label includes storage instructions and standard warnings.*

FDA Label Image

Table 1 (Doxazosin Fig1)

A data table titled 'Summary of Effectiveness Data in Placebo Controlled Trials' presenting symptom scores and maximum flow rates for Doxazosin versus placebo across three studies with varying doses and durations. The table includes baseline means, mean changes, and sample sizes. Adjacent is a bar chart illustrating symptom score and maximum flow rate changes for placebo, 4 mg, and 8 mg doses from Study 2, highlighting statistical significance.*

FDA Label Image

Figure 1 – Study 1 (Doxazosin Fig2)

Two line graphs comparing Doxazosin and placebo over 14 weeks. The first graph shows mean change in total symptom score from baseline, with Doxazosin showing a greater decrease than placebo. The second graph shows mean increase in maximum urinary flow rate (mL/sec) from baseline, where Doxazosin shows a higher improvement than placebo. Both graphs include error bars and sample sizes (N=47 for placebo, N=50 for Doxazosin).*

FDA Label Image

Chemical Structure (Doxazosin Str)

Chemical structure of the active ingredient doxazosin as shown in the molecular diagram, including its sulfomethane (CH3SO3H) group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.